CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells

MLA

Manic, Gwenola, et al. “CHK1-Targeted Therapy to Deplete DNA Replication-Stressed, P53-Deficient, Hyperdiploid Colorectal Cancer Stem Cells.” Gut, vol. 67, no. 5, Jan. 2018, pp. 903–17. EBSCOhost, https://doi.org/10.1136/gutjnl-2016-312623.

APA

Manic, G., Signore, M., Sistigu, A., Russo, G., Corradi, F., Siteni, S., Musella, M., Vitale, S., De Angelis, M. L., Pallocca, M., Amoreo, C. A., Sperati, F., Di Franco, S., Barresi, S., Policicchio, E., De Luca, G., De Nicola, F., Mottolese, M., Zeuner, A., … De Maria, R. (2018). CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells. Gut, 67(5), 903–917. https://doi.org/10.1136/gutjnl-2016-312623

Chicago

Manic, Gwenola, Michele Signore, Antonella Sistigu, Giorgio Russo, Francesca Corradi, Silvia Siteni, Martina Musella, et al. 2018. “CHK1-Targeted Therapy to Deplete DNA Replication-Stressed, P53-Deficient, Hyperdiploid Colorectal Cancer Stem Cells.” Gut 67 (5): 903–17. doi:10.1136/gutjnl-2016-312623.